Pancreatic Cancer Research

ResearcherJiaxing UniversityNo recent work listed

Zhengxiang Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2270-4140; OpenAlex author ID A5058036976. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2017: 2 papers · 2018: 2 papers · 2019: none · 2020: 2 papers · 2021: 4 papers · 2022: none · 2023: 1 paper

Papers 11

  1. Plasma lipid levels are associated with the CD8+ T-cell infiltration and prognosis of patients with pancreatic cancer. Co-author DOI 10.1002/cam4.6080↗
  2. The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer. Last author DOI 10.1080/21655979.2021.1934243↗
  3. The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis. Co-author DOI 10.1186/s12957-021-02420-1↗
  4. CXCL10 Expression in Tumor Tissues and is An Independent Prognostic Indicator of Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-966327/v1↗
  5. Clinical prognostic value of circulating tumor cells in the treatment of pancreatic cancer with gemcitabine chemotherapy. Last author DOI 10.3892/etm.2021.10574↗
  6. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas. Co-author DOI 10.3892/mmr.2020.11504↗
  7. CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer. Last author DOI 10.3892/ol.2020.12120↗
  8. Detection of K-ras gene mutations in feces by magnetic nanoprobe in patients with pancreatic cancer: A preliminary study. Co-author DOI 10.3892/etm.2017.5368↗
  9. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer. Last author DOI 10.3892/or.2018.6761↗
  10. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2174/1566524018666180308115705↗
  11. [Alpha-fetoprotein-producing pancreatic cancer: a case report]. Last author DOI 10.3760/cma.j.issn.0253-3766.2017.06.015↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoguang Wang · 8 shared papers, 2017–2023 · strength 1.02
  2. Lingyu Hu · 4 shared papers, 2021 · strength 0.64
  3. Haokai Xu · 4 shared papers, 2020–2021 · strength 0.58
  4. Bin Yan Wu · 4 shared papers, 2017–2021 · strength 0.50
  5. Fei Chen · 3 shared papers, 2018–2021 · strength 0.36
  6. Zhengwei Song · 3 shared papers, 2018–2021 · strength 0.33
  7. Yiyu Shen · 2 shared papers, 2020–2021 · strength 0.30
  8. Bin Wu · 2 shared papers, 2018–2021 · strength 0.27
  9. Wei Chen · 2 shared papers, 2020–2021 · strength 0.25
  10. Bin Wu · 1 shared paper, 2023 · strength 0.20
  11. Xujian Chen · 1 shared paper, 2023 · strength 0.20
  12. Jun Gao · 2 shared papers, 2017–2018 · strength 0.15
  13. Jing Wang · 1 shared paper, 2020 · strength 0.13
  14. Tianpeng Wang · 1 shared paper, 2017 · strength 0.12
  15. Lifeng Qi · 1 shared paper, 2018 · strength 0.11
  16. Fei Chen · 1 shared paper, 2018 · strength 0.08
  17. Kaixuan Wang · 1 shared paper, 2018 · strength 0.08
  18. Z S Li · 1 shared paper, 2017 · strength 0.07
  19. J. Zhang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.